Skip to main content
Resources & Evidence Contact us

Preterm nutrition products

None

None

None

Benefits of an Exclusive Human Milk Diet (EHMD)

More than 20 clinical studies with more than 5,000 premature infants have demonstrated the effectiveness of Prolacta’s 100% human milk-based nutritional products.1

Data on file.

Our products, as part of an exclusive human milk diet, have been shown in clinical studies to:

HumavantTM CR Human Milk Caloric Fortifier

Human milk caloric fortifier is ideal for neonatal infants receiving low caloric content. Data show that 65% of the time, term mother’s own milk (MOM) is less than 20 Cal/30 ml.12

Wojcik K, et al. Macronutrient analysis of a nationwide sample of donor breast milk. J Am Diet Assoc. 2009;109(1):137-140. doi:10.1016/j.jada.2008.10.008.

Humavant CR human milk caloric fortifier can meet the need for additional calories.

  • Intended for use with MOM or donor milk (DM) to increase lipids and achieve adequate growth
  • Formulated to deliver at least 2.6 Cal/ml
  • Available frozen in 30 ml bottles containing 10 ml of product
    (4 bottles per unit carton, with 48-hour expiration)
  • Includes simplified preparation instructions
  • Easy to use and measure

Humavant CR human milk caloric fortifier is the only completely human solution created to add calories to MOM or DM without substantially increasing volume and without introducing a non-human milk-based nutritional product.

A randomised clinical trial found that premature infants, who received an exclusive human milk diet (EHMD) with Humavant CR fortifier, had superior length and weight velocity compared to infants who received an EHMD without Humavant CR fortifier.13

Hair AB, et al. Randomized trial of human milk cream as a supplement to standard fortification of an exclusive human milk-based diet in infants 750-1250 g birth weight. J Pediatr. November 2014;165(5):915-20. doi:10.1016/j.jpeds.2014.07.005.

Preterm infants who received Humavant CR fortifier had a significantly earlier post-menstrual age (PMA) at discharge and trended toward decreased length of stay when compared to those who did not receive Humavant CR fortifier.14

Hair AB, et al. Premature infants 750-1250 g birth weight supplemented with a novel human milk-derived cream are discharged sooner. Breastfeed Med. 2016;11(3):133-137. doi:10.1089/bfm.2015.0166

,15

Results were significant after adjusting for whether the baby had BPD, their gestational age, and their birth weight.

This study is a subset analysis of data originally published in 2014 by Hair et al in The Journal of Pediatrics.

Clinical Studies and Publications:

  • Randomised Trial of Human Milk Cream as a Supplement to Standard Fortification of an Exclusive Human Milk-Based Diet in Infants 750-1,250 g Birth Weight
  • Premature Infants 750–1,250g Birth Weight Supplemented with a Novel Human Milk-Derived Cream Are Discharged Sooner
  • Fortifier and Cream Improve Fat Delivery in Continuous Enteral Infant Feeding of Breast Milk
  • Macronutrient analysis of a nationwide sample of donor breast milk

Product information downloads

Supplemental product info

Product specification sheet

Preparation guidelines

Nutrition information

Humavant CR preparation log sheet

Humavant® RTF

Humavant® RTF (Ready-To-Feed) offers Neonatal Intensive Care Units superior solutions for their extremely premature infants when mother’s own milk is not available.

Human Milk-Based Premature Infant Formula

Human donor milk

Pasteurised, standardised, quality human donor milk

The benefits of breast milk are well established and breastfeeding is highly recommended by healthcare professionals.

Since 2012, the American Academy of Pediatrics (AAP) has recommended the use of human milk for all preterm infants, whether MOM or pasteurised human donor milk, if MOM is unavailable.11

American Academy of Pediatrics. Breastfeeding and the use of human milk. Section on Breastfeeding. Pediatrics. 2012;129(3):e827-e841. doi:10.1542/peds.2011-3552

Guaranteed supply

Only Prolacta offers a guaranteed supply of donor human milk based on your NICU’s usage forecast – that means no more worrying about supply shortages.12

Data Available by Request

Standardised nutrition

  • The first donor human milk formulated to a minimum of 20 kcal/30 ml
  • The first donor human milk to provide an average of 1.0 g protein/100 ml1

    Data on File

  • Two-year shelf life supported by real-time stability studies on every batch1

    Data on File

  • Available in two sizes for flexibility in feeding premature infants
  • Can be administered within 48 hours once the thawing process begins1

    Data on File

  • Labelled in accordance with U.S. FDA food labelling requirements

Industry-leading quality and safety

  • The only donor human milk verified by DNA matching to the donor
  • Milk is tested for B. cereus and for adulteration, nicotine and drugs of abuse
  • Each donation is tested using nucleic acid testing for HIV-1 & 2, HTLV I & II, HBV, HCV, syphilis and ZIKV
  • Processed in a pharmaceutical-grade manufacturing facility

Product information downloads

Prolact HM® Product Specification Sheet

Prolact HM® Supplemental Product Info

Prolact HM® Preparation Log Sheet

PremieLact Product Specification Sheet

PremieLact Supplemental Product Info

PremieLact Preparation Log Sheet

Overcoming complications

Prolacta’s products, when used as part of an exclusive human milk diet, have been shown to reduce the incidence of clinical complications.

In a multicentre, retrospective cohort study with 1,587 patients, the outcomes of extremely premature infants (< 1,250 g birthweight) who received a diet including cow’s milk-based products were compared with infants who received an EHMD. The incidence of mortality, necrotising enterocolitis (NEC), bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP) and late-onset sepsis were all reduced with an EHMD.13

Hair AB, Peluso AM, Hawthorne KM, et al. Beyond necrotizing enterocolitis prevention: improving outcomes with an exclusive human milk-based diet. Breastfeed Med. 2016;11(2):70-74. doi:10.1089/bfm.2015.0134. Published correction appears in Breastfeed Med. 2017;12(10):663. doi:10.1089/bfm.2015.0134.correx








Improving outcomes with Prolacta's exclusive human milk diet

Reducing hospital costs with an EHMD

Very low birthweight babies are at risk for prematurity-related morbidities and interventions, such as BPD, ROP, late-onset sepsis and NEC. The incremental cost of these morbidities and interventions can substantially increase the cost of NICU hospitalisation.

Tell us how we can help

Doctor-to-doctor guidance

Coding, billing and reimbursement questions

Finding my sales representative

Support with an order

Citations

1 Data on file.

2 Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol. 2016;36(3):216-220. doi:10.1038/jp.2015.168

3 Abrams SA, Schanler RJ, Lee ML, Rechtman DJ. Greater mortality and morbidity in extremely preterm infants fed a diet containing cow milk protein products. Breastfeed Med. 2014;9(6):281-285. doi:10.1089/bfm.2014.0024

4 Cristofalo EA, Schanler RJ, Blanco CL, et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr. 2013;163(6):1592-1595. doi:10.1016/j.jpeds.2013.07.011

5 Sullivan S, Schanler RJ, Kim JH, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. 2010;156(4):562-567. doi:10.1016/j.jpeds.2009.10.040

6 Huston RK, Markell AM, McCulley EA, Gardiner SK, Sweeney SL. Improving growth for infants ≤1250 grams receiving an exclusive human milk diet. Nutr Clin Pract. 2018;33(5):671-678. doi:10.1002/ncp.10054

7 Huston RK, Lee ML, Rider ED, et al. Early fortification of enteral feedings for infants <1250 grams birth weight receiving a human milk diet including human milk based fortifier. J Neonatal Perinatal Med. 2019. [Epub ahead of print]. doi:10.3233/NPM-190300

8 Hair AB, Bergner EM, Gollins LA, et al. Long-term outcomes at 2 and 5 years from the randomized controlled trial: human milk cream as a supplement to standard fortification of an exclusive human milk-based diet in VLBW infants. Poster presented at: Pediatric Academic Societies Meeting. April 24 – May 1, 2019. Baltimore, MD.

9 Barile D, Lebrilla CB, German B, Rechtman DJ, Lee ML. Oligosaccharide prebiotics present in a breast milk based human milk fortifier. Presented at Hot Topics in Neonatology. Washington DC December 2008

10 Smilowitz JT, Lebrilla CB, Mills DA, German JB, Freeman SL. Breast milk oligosaccharides: structure-function relationships in the neonate. Annu Rev Nutr. 2014;34:143-169. doi:10.1146/annurev-nutr-071813-105721

11 Ruhaak LR, Stroble C, Underwood MA, Lebrilla CB. Detection of milk oligosaccharides in plasma of infants. Anal Bioanal Chem. 2014;406(24):5775-5784. doi:10.1007/s00216-014-8025-z

12 Wojcik K, et al. Macronutrient analysis of a nationwide sample of donor breast milk. J Am Diet Assoc. 2009;109(1):137-140. doi:10.1016/j.jada.2008.10.008.

13 Hair AB, et al. Randomized trial of human milk cream as a supplement to standard fortification of an exclusive human milk-based diet in infants 750-1250 g birth weight. J Pediatr. November 2014;165(5):915-20. doi:10.1016/j.jpeds.2014.07.005.

14 Hair AB, et al. Premature infants 750-1250 g birth weight supplemented with a novel human milk-derived cream are discharged sooner. Breastfeed Med. 2016;11(3):133-137. doi:10.1089/bfm.2015.0166

15 Results were significant after adjusting for whether the baby had BPD, their gestational age, and their birth weight.

16 Visuthranukul C, Abrams SA, Hawthorne KM, Hagan JL, Hair AB. Premature small for gestational age infants fed an exclusive human milk-based diet achieve catch-up growth without metabolic consequences at 2 years of age. Arch Dis Child Fetal Neonatal Ed. 2019;104(3);F242–F247. doi:10.1136/archdischild-2017-314547

We have updated our Privacy and Cookie Policies, effective 15 August, 2024. In accordance with these policies, when you visit our websites, we may collect data about you using cookies and similar third party tracking technologies (“Cookies”). Cookies may be necessary for the basic functionality of the website, as well as other purposes such as targeted advertising and analytics. Your continued use of the website constitutes your consent to Cookies. For more information on our privacy practices, including how to manage certain types of Cookies, please visit Privacy Policy and Cookie Policy.

Do not sell or share my personal information

(888) 776-5228

info@prolacta.com


(844) 707-7482

privacy@prolacta.com